Stock Stories - Bamboo Works - China stock insights for global investors

Stories About 2096.HK

BRIEF: Simcere Pharma profit surges in 2025

2026-02-26

Founded in 1995, Simcere develops, makes and sells oncology and cardiovascular drugs. The company was listed in the U.S. in 2007, but delisted in 2013, before re-listing in Hong Kong in 2020.

FAST NEWS: Simcere’s profit plunges on investment losses

2024-07-31

The pharmaceutical company’s profits have been buffeted by erratic returns on an equity stake in a fellow developer of innovative drugs.

Profit setback for Simcere Pharma in novel drugs quest

2024-03-01

Founded in 1995, Simcere develops, makes and sells oncology and cardiovascular drugs.

FAST NEWS: Simcere’s Covid drug trial shows promising results

2024-01-19

Simcere Pharmaceutical announced Tuesday that it has signed a deal giving it exclusive commercialization rights for treatment of influenza indications using the innovative drug ADC189 from Jiaxing AnDiCon Biotech.

FAST NEWS: Simcere gets exclusive rights to innovative influenza drug

2023-10-11

Simcere Pharmaceutical Group Ltd. said on Thursday it expects to report its revenue grew between 24% and 26.3% to between 3.35 billion yuan ($468 million) and 3.41 billion yuan in the first half of 2023.

FAST NEWS: Simcere’s revenue jumps on rising innovative drug sales

2023-07-28

Discover hidden China stock gems in our weekly newsletter

Follow us

Subscribe to Our Free eNewsletter

Check out our content with some of our syndication partners